Literature DB >> 6721756

Laser trabeculoplasty primary therapy in open-angle glaucoma. A preliminary report.

A R Rosenthal, P R Chaudhuri, A P Chiapella.   

Abstract

Thirty-three patients with chronic open-angle glaucoma were treated with argon laser trabeculoplasty as the primary therapeutic modality. In 18 patients (55%) successful normalization of intraocular pressure (less than 21 mm Hg) was achieved. Of these, ten patients underwent bilateral procedures and eight patients underwent unilateral treatment. The IOP was normalized within five weeks in 27 of these 28 eyes. During the follow-up period, ranging from six to 18.5 months, IOP has remained lower than 21 mm Hg in all the successfully treated eyes. In 15 patients (45%) the treatment failed to control IOP by four weeks. In these patients, only one eye was treated. Significant correlations with successful outcome included initial IOP, well-delineated angle landmarks, and date of treatment. The date of treatment was consistent with an improvement in the treatment administration over time.

Entities:  

Mesh:

Year:  1984        PMID: 6721756     DOI: 10.1001/archopht.1984.01040030555015

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

1.  Argon laser trabeculoplasty controls one third of patients with progressive, uncontrolled open-angle glaucoma for five years.

Authors:  K A Baez; G L Spaeth
Journal:  Trans Am Ophthalmol Soc       Date:  1991

2.  Argon laser trabeculoplasty in primary open-angle glaucoma--results in black Jamaican population.

Authors:  B J Moriarty; J N Char; R W Acheson; D T Dunn
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

3.  Efficacy and safety of indomethacin 0.1% versus flurbiprofen 0.03% eyedrops in inflammation after argon laser trabeculoplasty. The Belgian Study Group on Glaucoma.

Authors:  M Goethals; L Missotten
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

4.  Laser trabeculoplasty as supplementary treatment for primary open angle glaucoma.

Authors:  M B Sherwood; J Lattimer; R A Hitchings
Journal:  Br J Ophthalmol       Date:  1987-03       Impact factor: 4.638

5.  A review of surgical alternatives to medical therapy for glaucoma.

Authors:  D E Gaasterland
Journal:  J Natl Med Assoc       Date:  1988-07       Impact factor: 1.798

6.  Long-term efficacy of primary laser trabeculoplasty.

Authors:  T Elsås; H Johnsen
Journal:  Br J Ophthalmol       Date:  1991-01       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.